elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26781643-4E2A5252-96E3-4348-9CDA-7548591ED0A9
Q26781643-4E2A5252-96E3-4348-9CDA-7548591ED0A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26781643-4E2A5252-96E3-4348-9CDA-7548591ED0A9
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling
P2860
Q26781643-4E2A5252-96E3-4348-9CDA-7548591ED0A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26781643-4E2A5252-96E3-4348-9CDA-7548591ED0A9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8a1f04ddca8e089f9f08a875689f952801b5aac
P2860
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.